← 產業報告目錄
Rigid Endoscopes Market by Type (Laparoscopes, Arthroscopes, Cystoscopes), Clinical Usage (Diagnostic, Surgical), Application (Laparoscopy, Cystoscopy, Arthroscopy, Other), End User (Hospitals, ASCs, Clinics), Region - Global Forecast to 2030
授權報價
| Single User Licence | $4,950 USD |
| Multi User Licence | $6,650 USD |
| Corporate User Licence | $8,150 USD |
| Global User Licence | $10,000 USD |
報告摘要
The global rigid endoscopes market is projected to reach USD 2.32 billion by 2030, growing from USD 1.83 billion in 2025, at a CAGR of 4.9% during the forecast period. The growth of the rigid endoscopes market is driven by the rising prevalence of chronic diseases, increasing demand for minimally invasive surgeries, and advancements in imaging and optics technology. Opportunities exist in emerging markets due to the expansion of healthcare infrastructure, increasing procedural volumes, and rising medical tourism, which enable the adoption of advanced endoscopic solutions. However, market growth faces challenges from risks of viral infections, lack of proper sterilization and reprocessing, and high procedural costs, which may limit widespread adoption, particularly in resource-constrained regions.
The arthroscopes segment is expected to grow at the fastest rate in the rigid endoscopes market during the forecast period.
By type, the rigid endoscopes market is segmented into laparoscopes, urology endoscopes, gynecology endoscopes, arthroscopes, cytoscopes, neuroendoscopes, and other rigid endoscopes. Among these, the urology endoscopes segment accounted for the second-largest market share in 2024, owing to the increasing prevalence of musculoskeletal disorders, particularly among the aging global population. According to the WHO, the number of people aged 60 and above is projected to rise from 1.1 billion in 2023 to 1.4 billion by 2030, creating a substantial patient pool at higher risk for joint-related conditions. Age-related degenerative diseases such as osteoarthritis are becoming more common, with the CDC reporting that arthritis prevalence increases sharply with age—from 3.6% in adults aged 18–34 to 53.9% in individuals 75 and older—driving demand for minimally invasive orthopedic interventions. Arthroscopy offers a precise, less invasive solution for diagnosing and treating joint injuries, reducing recovery time, and improving surgical outcomes, which enhances patient preference and procedural adoption. Additionally, advancements in high-definition imaging, improved surgical instruments, and growing awareness among orthopedic specialists are further accelerating the adoption of arthroscopes, positioning this segment for the fastest growth within the rigid endoscopes market.
The surgical usage segment accounted for the largest share of the rigid endoscopes market in 2024.
By clinical usage, the rigid endoscopes market has been divided into diagnostic & surgical usage. Among these, the surgical usage segment accounted for the largest share of the market in 2024. This is due to the increasing adoption of minimally invasive procedures across multiple specialties, including laparoscopy, arthroscopy, urology, gynecology, and ENT. Rigid endoscopes serve as the core platform for these interventions, offering superior optical clarity, high-definition and 4K visualization, and robust, autoclavable designs that integrate seamlessly with surgical instruments and operating room workflows. The growing preference for minimally invasive surgeries is driven by benefits such as shorter hospital stays, reduced post-operative complications, faster patient recovery, and enhanced clinical outcomes, which directly influence procedure volumes and market demand for rigid scopes.
Asia Pacific is projected to grow at the highest rate in the rigid endoscopes market during the forecast period.
The global rigid endoscopes market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these, the Asia Pacific region is projected to grow at the highest rate during the forecast period. This is primarily due to the development of healthcare infrastructure, increasing healthcare expenditure, and rising awareness of early disease detection across populous nations such as China and India. These countries are investing heavily to enhance diagnostic and surgical capabilities, particularly to manage the rising cases of chronic diseases, such as cancer, pulmonary, and urological disorders. Japan’s well-established healthcare system with universal insurance coverage ensures wide accessibility to advanced endoscopic procedures. Moreover, increasing medical tourism, favorable government initiatives, and the rising adoption of minimally invasive technologies are accelerating market penetration, making the Asia Pacific a high-growth region in the global rigid endoscopes market.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1 –40%, Tier 2 –30%, and Tier 3 –30%
• By Designation: C-level –50%, Director level –30%, and Others –20%
• By Region: North America –30%, Europe – 25%, Asia Pacific –20%, Latin America –15%, and Middle East & Africa –10%
Notes:
Companies are classified into tiers based on their total revenue. The tiers are as follows: Tier 1 = >USD 10.0 billion, tier 2 = USD 1.0 billion to USD 10.0 billion, and tier 3 = <USD 1.0 billion
C-level primaries include CEOs, CFOs, COOs, and VPs.
Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The players operating in the rigid endoscopes market include Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Stryker (US), Medtronic (Ireland), Smith+Nephew (UK), B Braun SE (Germany), CONMED Corporation (US), Arthrex Inc. (US), Nipro (Japan), FUJIFILM Corporation (Japan), Hologic, Inc. (US), Shangrao WS Medtech Co., Ltd (China), Henke-Sass, Wolf (Germany), RUDOLF Medical GmbH + Co. KG (Germany), EndoMed Systems GmbH (Germany), Teleflex Incorporated (US), Integrated Endoscopy (US), NeoScope, Inc. (US), Ecleris (US), Nanchang WOEK Medical Technology Co., Ltd (China), Richard Wolf GmbH. (Germany), ATMOS MedizinTechnik GmbH & Co. KG (Germany), Kashmir Surgical Works. (India), Optomic (Spain), and HIPP ENDOSKOP SERVICE GMBH (Germany)
Research Coverage
This report examines the rigid endoscopes market by type, application, end user, and region. The report also examines key factors (including drivers, restraints, opportunities, and challenges) influencing market growth and provides an in-depth analysis of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as smaller entrants to gauge the market's pulse, which, in turn, will help them gain a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence.
This report provides insights into the following pointers:
• Analysis of key drivers (increasing investments, funds, and grants by government and other organizations, growing focus of hospitals to expand endoscopic units, increasing preference for minimally invasive surgeries, rising need for endoscopy to diagnose & treat target diseases), restraints (high overhead costs of endoscopy procedures, increased risk of getting infections during endoscopic procedures), opportunities (rapidly developing healthcare sector in emerging countries), challenges (increasing number of product recalls, lack of sterilization & reprocessing)
• Market Penetration: Complete knowledge of the spectrum of products presented by the major companies in the rigid endoscopes market
• Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and product launches within the rigid endoscopes market
• Market Development: Complete knowledge about profitable developing regions
• Market Diversification: Exhaustive knowledge of new goods, expanding geographies, and current changes in the rigid endoscopes industry helps to diversify the market
• Competitive Assessment: In-depth assessment of market share, growth strategies, and product offerings of leading players like Olympus Corporation (Japan), Karl Storz SE & CO. KG (Germany), Stryker (US), Nipro (Japan), EndoMed Systems GmbH (Germany), Richard Wolf GmbH. (Germany), Ambu A/S (Denmark), Smith+Nephew (UK), and others.
目錄 Table of Contents
1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
1.3 STUDY SCOPE 24
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 24
1.3.2 INCLUSIONS & EXCLUSIONS 25
1.3.3 YEARS CONSIDERED 26
1.3.4 CURRENCY CONSIDERED 26
1.4 STAKEHOLDERS 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
2.1.1 SECONDARY DATA 29
2.1.1.1 Key objectives of secondary research 29
2.1.1.2 Key data from secondary sources 30
2.1.2 PRIMARY DATA 30
2.1.2.1 Key primary sources 31
2.1.2.2 Key objectives of primary research 31
2.1.2.3 Key industry insights 32
2.1.2.4 Key data from primary sources 33
2.2 MARKET SIZE ESTIMATION 34
2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 34
2.2.2 TOP-DOWN APPROACH 35
2.2.3 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS 35
2.2.4 DEMAND-SIDE ANALYSIS (USING RIGID ENDOSCOPES) 35
2.3 DATA TRIANGULATION 38
2.4 MARKET RANKING ANALYSIS 39
2.5 STUDY ASSUMPTIONS 39
2.6 RESEARCH LIMITATIONS 39
2.6.1 METHODOLOGY-RELATED LIMITATIONS 39
2.6.2 SCOPE-RELATED LIMITATIONS 40
2.7 RISK ASSESSMENT 40
3 EXECUTIVE SUMMARY 41
4 PREMIUM INSIGHTS 45
4.1 RIGID ENDOSCOPES MARKET OVERVIEW 45
4.2 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY END USER AND COUNTRY 46
4.3 RIGID ENDOSCOPES MARKET: GEOGRAPHIC MIX 47
4.4 RIGID ENDOSCOPES MARKET: EMERGING VS. DEVELOPED ECONOMIES 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
5.2.1 DRIVERS 50
5.2.1.1 Growing preference for minimally invasive surgeries 50
5.2.1.2 Increasing burden of chronic and lifestyle-related diseases 50
5.2.2 RESTRAINTS 51
5.2.2.1 High overhead costs 51
5.2.2.2 Risk of viral infections during endoscopic procedures 51
5.2.3 OPPORTUNITIES 52
5.2.3.1 Rapidly developing healthcare sector in emerging economies 52
5.2.4 CHALLENGES 52
5.2.4.1 Product recalls 52
5.2.4.2 Lack of sterilization and reprocessing 53
5.3 INDUSTRY TRENDS 54
5.3.1 ADVANCED IMAGING TECHNOLOGIES 54
5.3.2 MINIATURIZATION AND ULTRA-SLIM DESIGNS 54
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 54
5.5 PRICING ANALYSIS 55
5.5.1 AVERAGE SELLING PRICE TREND A OF RIGID ENDOSCOPES,
BY KEY PLAYER, 2022–2024 55
5.5.2 AVERAGE PRICING TREND OF RIGID ENDOSCOPES, BY REGION, 2022–2024 56
5.6 VALUE CHAIN ANALYSIS 57
5.7 SUPPLY CHAIN ANALYSIS 58
5.8 ECOSYSTEM ANALYSIS 60
5.9 INVESTMENT & FUNDING SCENARIO 61
5.10 TECHNOLOGY ANALYSIS 61
5.10.1 KEY TECHNOLOGIES 62
5.10.1.1 Illumination technology 62
5.10.2 COMPLEMENTARY TECHNOLOGIES 62
5.10.2.1 Surgical visualization 62
5.10.3 ADJACENT TECHNOLOGIES 62
5.10.3.1 3D endoscopic visualization 62
5.11 TRADE ANALYSIS 63
5.11.1 IMPORT DATA FOR HS CODE 9018, 2019–2024 63
5.11.2 EXPORT DATA FOR HS CODE 9018, 2019–2024 63
5.12 REGULATORY ANALYSIS 64
5.12.1 REGULATORY LANDSCAPE 64
5.12.1.1 North America 64
5.12.1.1.1 US 64
5.12.1.1.2 Canada 65
5.12.1.2 Europe 66
5.12.1.3 Asia Pacific 66
5.12.1.3.1 Japan 66
5.12.1.3.2 China 67
5.12.1.3.3 India 68
5.12.1.4 Latin America 68
5.12.1.5 Middle East & Africa 68
5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 69
5.13 PATENT ANALYSIS 71
5.13.1 PATENT PUBLICATION TREND 71
5.13.2 JURISDICTION AND TOP APPLICANT ANALYSIS 73
5.13.3 LIST OF PATENTS 73
5.14 KEY CONFERENCES & EVENTS, 2025–2026 75
5.15 PORTER’S FIVE FORCES ANALYSIS 76
5.15.1 THREAT OF NEW ENTRANTS 77
5.15.2 THREAT OF SUBSTITUTES 77
5.15.3 BARGAINING POWER OF BUYERS 77
5.15.4 BARGAINING POWER OF SUPPLIERS 77
5.15.5 INTENSITY OF COMPETITIVE RIVALRY 77
5.16 KEY STAKEHOLDERS & BUYING CRITERIA 77
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 78
5.16.2 BUYING CRITERIA 78
5.17 ADJACENT MARKET ANALYSIS 80
5.17.1 FLEXIBLE ENDOSCOPES MARKET 80
5.18 UNMET NEEDS/END-USER EXPECTATIONS 81
5.19 IMPACT OF AI/GEN AI ON RIGID ENDOSCOPES MARKET 81
5.19.1 INTRODUCTION 81
5.19.2 AI USE CASES 82
5.19.3 KEY COMPANIES IMPLEMENTING AI 83
5.19.4 FUTURE OF GENERATIVE AI ON RIGID ENDOSCOPES MARKET 83
5.20 IMPACT OF 2025 US TARIFFS ON RIGID ENDOSCOPES MARKET 84
5.20.1 INTRODUCTION 84
5.20.2 KEY TARIFF RATES 85
5.20.3 PRICE IMPACT ANALYSIS 86
5.20.4 IMPACT ON REGION 86
5.20.4.1 North America 86
5.20.4.2 Europe 86
5.20.4.3 Asia Pacific 87
5.20.5 IMPACT ON END-USE INDUSTRY 87
6 RIGID ENDOSCOPES MARKET, BY TYPE 88
6.1 INTRODUCTION 89
6.2 LAPAROSCOPES 89
6.2.1 RISING GLOBAL PREVALENCE OF GYNECOLOGICAL AND
CANCER CONDITIONS TO PROPEL MARKET GROWTH 89
6.3 UROLOGY ENDOSCOPES 90
6.3.1 RISING UROLOGICAL DISORDERS AND TECHNOLOGICAL ADVANCES TO DRIVE GROWTH IN UROLOGY ENDOSCOPES SEGMENT 90
6.4 GYNECOLOGY ENDOSCOPES 91
6.4.1 INCREASING PREVALENCE OF GYNECOLOGICAL CANCERS
AMONG WOMEN TO AID MARKET GROWTH 91
6.5 ARTHROSCOPES 92
6.5.1 RISING GERIATRIC POPULATION AND GROWING INCIDENCE OF ORTHOPEDIC DISEASES TO BOOST MARKET GROWTH 92
6.6 CYSTOSCOPES 94
6.6.1 RISING BLADDER CANCER CASES AND MINIMALLY INVASIVE
BENEFITS TO DRIVE CYSTOSCOPES MARKET GROWTH 94
6.7 NEUROENDOSCOPES 95
6.7.1 RISING NEUROLOGICAL DISORDERS AND INVESTMENTS IN ADVANCED CARE TO DRIVE MARKET GROWTH 95
6.8 OTHER RIGID ENDOSCOPES 97
7 RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE 98
7.1 INTRODUCTION 99
7.2 SURGICAL USAGE 99
7.2.1 RISING ADOPTION OF MINIMALLY INVASIVE SURGERIES TO DRIVE SEGMENTAL GROWTH 99
7.3 DIAGNOSTIC USAGE 100
7.3.1 GROWING DEMAND FOR OFFICE-BASED ENT, GYNECOLOGY, AND UROLOGY PROCEDURES TO ACCELERATE GROWTH 100
8 RIGID ENDOSCOPES MARKET, BY APPLICATION 102
8.1 INTRODUCTION 103
8.2 LAPAROSCOPY 103
8.2.1 BROAD CLINICAL APPLICABILITY AND STRONG PROCEDURAL DEMAND ACROSS DIAGNOSTIC AND THERAPEUTIC INTERVENTIONS TO AID GROWTH 103
8.3 UROLOGY ENDOSCOPY 105
8.3.1 RISING PREVALENCE OF URINARY TRACT DISEASES AND CANCERS TO FUEL MARKET 105
8.4 ARTHROSCOPY 106
8.4.1 INCREASING PREVALENCE OF ARTHRITIS AMONG AGING POPULATION TO SPUR GROWTH 106
8.5 NEUROENDOSCOPY 108
8.5.1 FAVORABLE GOVERNMENT AND PRIVATE SECTOR POLICIES
TO SUPPORT ADOPTION OF NEUROENDOSCOPES 108
8.6 OTHER APPLICATIONS 110
9 RIGID ENDOSCOPES MARKET, BY END USER 111
9.1 INTRODUCTION 112
9.2 HOSPITALS 112
9.2.1 ROBUST SURGICAL INFRASTRUCTURE AND LARGE PATIENT BASE
TO FOSTER GROWTH 112
9.3 AMBULATORY SURGERY CENTERS 113
9.3.1 GROWING PREFERENCE FOR OUTPATIENT SURGERIES AND
TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET 113
9.4 CLINICS 115
9.4.1 RISING ADOPTION OF OUTPATIENT DIAGNOSTICS AND
DECENTRALIZED HEALTHCARE TO AID GROWTH 115
9.5 OTHER END USERS 116
10 RIGID ENDOSCOPES MARKET, BY REGION 117
10.1 INTRODUCTION 118
10.2 NORTH AMERICA 119
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 120
10.2.2 US 123
10.2.2.1 US to dominate North American rigid endoscopes
market during forecast period 123
10.2.3 CANADA 125
10.2.3.1 Rising chronic disease prevalence among aging
population to drive market 125
10.3 EUROPE 127
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 127
10.3.2 GERMANY 130
10.3.2.1 Germany to dominate European rigid endoscopes market 130
10.3.3 UK 132
10.3.3.1 Increased aging population, high cancer prevalence,
and strong healthcare infrastructure to drive market growth 132
10.3.4 FRANCE 134
10.3.4.1 Increase in health expenditure and high prevalence of
cancer to stimulate market growth 134
10.3.5 ITALY 136
10.3.5.1 Increasing prevalence of chronic diseases to boost adoption 136
10.3.6 SPAIN 137
10.3.6.1 Rising aging population to drive market growth 137
10.3.7 REST OF EUROPE 139
10.4 ASIA PACIFIC 141
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 141
10.4.2 CHINA 145
10.4.2.1 China to dominate Asia Pacific rigid endoscopes
market during forecast period 145
10.4.3 JAPAN 147
10.4.3.1 Increasing chronic disease prevalence and rising geriatric
population to drive growth 147
10.4.4 INDIA 148
10.4.4.1 Rising osteoarthritis and cancer prevalence to drive market growth 148
10.4.5 AUSTRALIA 150
10.4.5.1 Advancing healthcare infrastructure to support rigid endoscopes adoption in Australia 150
10.4.6 SOUTH KOREA 152
10.4.6.1 Super-aged society and high disease prevalence to drive
growth in South Korean market 152
10.4.7 REST OF ASIA PACIFIC 154
10.5 LATIN AMERICA 155
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 155
10.5.2 BRAZIL 158
10.5.2.1 Brazil to account for largest share of Latin American market 158
10.5.3 MEXICO 160
10.5.3.1 Increasing minimally invasive procedures to support rigid endoscopes adoption 160
10.5.4 REST OF LATIN AMERICA 161
10.6 MIDDLE EAST & AFRICA 163
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 163
10.6.2 GCC COUNTRIES 166
10.6.2.1 High healthcare investments and hospital expansions to drive market growth 166
10.6.3 REST OF MIDDLE EAST & AFRICA 168
11 COMPETITIVE LANDSCAPE 170
11.1 INTRODUCTION 170
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 170
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
IN RIGID ENDOSCOPES MARKET 170
11.3 REVENUE ANALYSIS, 2020–2024 171
11.4 MARKET SHARE ANALYSIS, 2024 172
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 175
11.5.1 STARS 175
11.5.2 EMERGING LEADERS 175
11.5.3 PERVASIVE PLAYERS 175
11.5.4 PARTICIPANTS 175
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 177
11.5.5.1 Company footprint 177
11.5.5.2 Region footprint 178
11.5.5.3 Type footprint 179
11.5.5.4 Application footprint 180
11.5.5.5 End-user footprint 181
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 181
11.6.1 PROGRESSIVE COMPANIES 181
11.6.2 RESPONSIVE COMPANIES 181
11.6.3 DYNAMIC COMPANIES 182
11.6.4 STARTING BLOCKS 182
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 183
11.6.5.1 Detailed list of key startups/SMEs 183
11.6.5.2 Competitive benchmarking of key startups/SMEs 184
11.7 COMPANY VALUATION & FINANCIAL METRICS 185
11.7.1 FINANCIAL METRICS 185
11.7.2 COMPANY VALUATION 185
11.8 BRAND/PRODUCT COMPARISON 186
11.9 COMPETITIVE SCENARIO 186
11.9.1 PRODUCT LAUNCHES 186
11.9.2 DEALS 187
12 COMPANY PROFILES 188
12.1 KEY PLAYERS 188
12.1.1 OLYMPUS CORPORATION 188
12.1.1.1 Business overview 188
12.1.1.2 Products offered 189
12.1.1.3 Recent developments 191
12.1.1.3.1 Deals 191
12.1.1.4 MnM view 191
12.1.1.4.1 Right to win 191
12.1.1.4.2 Strategic choices 192
12.1.1.4.3 Weaknesses & competitive threats 192
12.1.2 KARL STORZ SE & CO. KG 193
12.1.2.1 Business overview 193
12.1.2.2 Products offered 193
12.1.2.3 Recent developments 195
12.1.2.3.1 Product launches 195
12.1.2.3.2 Deals 195
12.1.2.4 MnM view 196
12.1.2.4.1 Right to win 196
12.1.2.4.2 Strategic choices 196
12.1.2.4.3 Weaknesses & competitive threats 196
12.1.3 STRYKER 197
12.1.3.1 Business overview 197
12.1.3.2 Products offered 198
12.1.3.3 MnM view 199
12.1.3.3.1 Right to win 199
12.1.3.3.2 Strategic choices 199
12.1.3.3.3 Weaknesses & competitive threats 199
12.1.4 SMITH+NEPHEW 200
12.1.4.1 Business overview 200
12.1.4.2 Products offered 201
12.1.4.3 MnM view 202
12.1.4.3.1 Right to win 202
12.1.4.3.2 Strategic choices 202
12.1.4.3.3 Weaknesses & competitive threats 202
12.1.5 B. BRAUN SE 203
12.1.5.1 Business overview 203
12.1.5.2 Products offered 204
12.1.5.3 MnM view 205
12.1.5.3.1 Right to win 205
12.1.5.3.2 Strategic choices 205
12.1.5.3.3 Weaknesses & competitive threat 205
12.1.6 MEDTRONIC 206
12.1.6.1 Business overview 206
12.1.6.2 Products offered 207
12.1.6.3 Recent developments 208
12.1.6.3.1 Deals 208
12.1.7 NIPRO 209
12.1.7.1 Business overview 209
12.1.7.2 Products offered 210
12.1.8 RICHARD WOLF GMBH 211
12.1.8.1 Business overview 211
12.1.8.2 Products offered 211
12.1.8.3 Recent developments 212
12.1.8.3.1 Deals 212
12.1.9 CONMED CORPORATION 213
12.1.9.1 Business overview 213
12.1.9.2 Products offered 214
12.1.10 ARTHREX, INC. 215
12.1.10.1 Business overview 215
12.1.10.2 Products offered 215
12.2 OTHER PLAYERS 216
12.2.1 FUJIFILM CORPORATION 216
12.2.2 HOLOGIC, INC. 217
12.2.3 SHANGRAO WS MEDTECH CO., LTD. 218
12.2.4 ATMOS MEDIZINTECHNIK GMBH & CO. KG 219
12.2.5 HENKE-SASS WOLF 220
12.2.6 RUDOLF MEDICAL GMBH + CO. KG 221
12.2.7 ENDOMED SYSTEMS GMBH 222
12.2.8 TELEFLEX INCORPORATED 223
12.2.9 INTEGRATED ENDOSCOPY 224
12.2.10 NEOSCOPE INC. 225
12.2.11 ECLERIS 226
12.2.12 NANCHANG WOEK MEDICAL TECHNOLOGY CO., LTD 227
12.2.13 KASHMIR SURGICAL WORKS 228
12.2.14 OPTOMIC 229
12.2.15 HIPP ENDOSKOP SERVICE GMBH 230
13 APPENDIX 231
13.1 DISCUSSION GUIDE 231
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 237
13.3 CUSTOMIZATION OPTIONS 239
13.4 RELATED REPORTS 239
13.5 AUTHOR DETAILS 240
圖表清單 List of Tables & Figures
TABLE 1 RIGID ENDOSCOPES MARKET: INCLUSIONS & EXCLUSIONS 25
TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2019–2024 26
TABLE 3 RIGID ENDOSCOPES MARKET: STUDY ASSUMPTIONS 39
TABLE 4 RIGID ENDOSCOPES MARKET: RISK ASSESSMENT 40
TABLE 5 PRODUCT RECALLS BY KEY PLAYERS, 2024–2025 53
TABLE 6 AVERAGE SELLING PRICE TREND OF RIGID ENDOSCOPES, BY KEY PLAYER,
2022–2024 (USD) 56
TABLE 7 AVERAGE SELLING PRICE TREND OF RIGID ENDOSCOPES, BY REGION,
2022–2024 (USD) 56
TABLE 8 IMPORT DATA FOR RIGID ENDOSCOPES UNDER HS CODE 9018, BY COUNTRY, 2019–2024 (USD THOUSAND) 63
TABLE 9 EXPORT DATA FOR RIGID ENDOSCOPES UNDER HS CODE 9018, BY COUNTRY, 2019–2024 (USD THOUSAND) 64
TABLE 10 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 65
TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 65
TABLE 12 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 66
TABLE 13 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES IN JAPAN 67
TABLE 14 NMPA MEDICAL DEVICES CLASSIFICATION 67
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 69
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 69
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 70
TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 70
TABLE 19 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 71
TABLE 20 RIGID ENDOSCOPES MARKET: LIST OF PATENTS, 2022−2025 73
TABLE 21 RIGID ENDOSCOPES MARKET: LIST OF KEY CONFERENCES & EVENTS,
JANUARY 2025–DECEMBER 2026 75
TABLE 22 RIGID ENDOSCOPES MARKET: PORTER’S FIVE FORCES 76
TABLE 23 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF
TOP THREE APPLICATIONS 78
TABLE 24 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 79
TABLE 25 RIGID ENDOSCOPES MARKET: UNMET NEEDS/END-USER EXPECTATIONS 81
TABLE 26 KEY COMPANIES IMPLEMENTING AI IN RIGID ENDOSCOPES MARKET 83
TABLE 27 US-ADJUSTED RECIPROCAL TARIFF RATES 85
TABLE 28 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR RIGID ENDOSCOPES 85
TABLE 29 RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 89
TABLE 30 LAPAROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 90
TABLE 31 UROLOGY ENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 91
TABLE 32 GYNECOLOGY ENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 92
TABLE 33 ARTHROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 93
TABLE 34 CYSTOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 94
TABLE 35 NEUROENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 96
TABLE 36 OTHER RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 97
TABLE 37 RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023–2030 (USD MILLION) 99
TABLE 38 RIGID ENDOSCOPES MARKET FOR SURGICAL USAGE, BY COUNTRY,
2023–2030 (USD MILLION) 100
TABLE 39 RIGID ENDOSCOPES MARKET FOR DIAGNOSTIC USAGE, BY COUNTRY,
2023–2030 (USD MILLION) 101
TABLE 40 RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 103
TABLE 41 RIGID ENDOSCOPES MARKET FOR LAPAROSCOPY, BY COUNTRY,
2023–2030 (USD MILLION) 104
TABLE 42 RIGID ENDOSCOPES MARKET FOR UROLOGY ENDOSCOPY, BY COUNTRY,
2023–2030 (USD MILLION) 106
TABLE 43 RIGID ENDOSCOPES MARKET FOR ARTHROSCOPY, BY COUNTRY,
2023–2030 (USD MILLION) 107
TABLE 44 RIGID ENDOSCOPES MARKET FOR NEUROENDOSCOPY, BY COUNTRY,
2023–2030 (USD MILLION) 109
TABLE 45 RIGID ENDOSCOPES MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2023–2030 (USD MILLION) 110
TABLE 46 RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION) 112
TABLE 47 RIGID ENDOSCOPES MARKET FOR HOSPITALS, BY COUNTRY,
2023–2030 (USD MILLION) 113
TABLE 48 RIGID ENDOSCOPES MARKET FOR AMBULATORY SURGERY CENTERS,
BY COUNTRY, 2023–2030 (USD MILLION) 114
TABLE 49 RIGID ENDOSCOPES MARKET FOR CLINICS, BY COUNTRY,
2023–2030 (USD MILLION) 115
TABLE 50 RIGID ENDOSCOPES MARKET FOR OTHER END USERS, BY COUNTRY,
2023–2030 (USD MILLION) 116
TABLE 51 RIGID ENDOSCOPES MARKET, BY REGION, 2023–2030 (USD MILLION) 119
TABLE 52 RIGID ENDOSCOPES MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 119
TABLE 53 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 121
TABLE 54 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE,
2023–2030 (USD MILLION) 121
TABLE 55 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE,
2023–2030 (THOUSAND UNITS) 122
TABLE 56 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 122
TABLE 57 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 123
TABLE 58 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY END USER,
2023–2030 (USD MILLION) 123
TABLE 59 US: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 124
TABLE 60 US: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 124
TABLE 61 US: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 125
TABLE 62 US: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION) 125
TABLE 63 CANADA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 126
TABLE 64 CANADA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 126
TABLE 65 CANADA: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 126
TABLE 66 CANADA: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION) 127
TABLE 67 EUROPE: RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 68 EUROPE: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 128
TABLE 69 EUROPE: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (THOUSAND UNITS) 129
TABLE 70 EUROPE: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 129
TABLE 71 EUROPE: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 129
TABLE 72 EUROPE: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION) 130
TABLE 73 GERMANY: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 131
TABLE 74 GERMANY: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 131
TABLE 75 GERMANY: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 131
TABLE 76 GERMANY: RIGID ENDOSCOPES MARKET, BY END USER,
2023–2030 (USD MILLION) 132
TABLE 77 UK: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 133
TABLE 78 UK: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 133
TABLE 79 UK: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 133
TABLE 80 UK: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION) 134
TABLE 81 FRANCE: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 134
TABLE 82 FRANCE: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 135
TABLE 83 FRANCE: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 135
TABLE 84 FRANCE: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION) 135
TABLE 85 ITALY: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 136
TABLE 86 ITALY: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 136
TABLE 87 ITALY: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 137
TABLE 88 ITALY: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION) 137
TABLE 89 SPAIN: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 138
TABLE 90 SPAIN: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 138
TABLE 91 SPAIN: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 138
TABLE 92 SPAIN: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION) 139
TABLE 93 REST OF EUROPE: RIGID ENDOSCOPES MARKET, BY TYPE,
2023–2030 (USD MILLION) 139
TABLE 94 REST OF EUROPE: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 140
TABLE 95 REST OF EUROPE: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 140
TABLE 96 REST OF EUROPE: RIGID ENDOSCOPES MARKET, BY END USER,
2023–2030 (USD MILLION) 140
TABLE 97 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 142
TABLE 98 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 143
TABLE 99 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY TYPE,
2023–2030 (THOUSAND UNITS) 143
TABLE 100 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 144
TABLE 101 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 144
TABLE 102 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY END USER,
2023–2030 (USD MILLION) 144
TABLE 103 CHINA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 145
TABLE 104 CHINA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 146
TABLE 105 CHINA: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 146
TABLE 106 CHINA: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION) 146
TABLE 107 JAPAN: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 147
TABLE 108 JAPAN: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 147
TABLE 109 JAPAN: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 148
TABLE 110 JAPAN: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION) 148
TABLE 111 INDIA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 149
TABLE 112 INDIA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 149
TABLE 113 INDIA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 150
TABLE 114 INDIA: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION) 150
TABLE 115 AUSTRALIA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 151
TABLE 116 AUSTRALIA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 151
TABLE 117 AUSTRALIA: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 151
TABLE 118 AUSTRALIA: RIGID ENDOSCOPES MARKET, BY END USER,
2023–2030 (USD MILLION) 152
TABLE 119 SOUTH KOREA: RIGID ENDOSCOPES MARKET, BY TYPE,
2023–2030 (USD MILLION) 152
TABLE 120 SOUTH KOREA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 153
TABLE 121 SOUTH KOREA: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 153
TABLE 122 SOUTH KOREA: RIGID ENDOSCOPES MARKET, BY END USER,
2023–2030 (USD MILLION) 153
TABLE 123 REST OF ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY TYPE,
2023–2030 (USD MILLION) 154
TABLE 124 REST OF ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 154
TABLE 125 REST OF ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 155
TABLE 126 REST OF ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY END USER,
2023–2030 (USD MILLION) 155
TABLE 127 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 156
TABLE 128 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE,
2023–2030 (USD MILLION) 156
TABLE 129 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE,
2023–2030 (THOUSAND UNITS) 157
TABLE 130 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 157
TABLE 131 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 157
TABLE 132 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY END USER,
2023–2030 (USD MILLION) 158
TABLE 133 BRAZIL: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 158
TABLE 134 BRAZIL: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 159
TABLE 135 BRAZIL: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 159
TABLE 136 BRAZIL: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION) 159
TABLE 137 MEXICO: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 160
TABLE 138 MEXICO: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 160
TABLE 139 MEXICO: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 161
TABLE 140 MEXICO: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION) 161
TABLE 141 REST OF LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE,
2023–2030 (USD MILLION) 162
TABLE 142 REST OF LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023–2030 (USD MILLION) 162
TABLE 143 REST OF LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 163
TABLE 144 REST OF LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY END USER,
2023–2030 (USD MILLION) 163
TABLE 145 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY REGION,
2023–2030 (USD MILLION) 164
TABLE 146 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY TYPE,
2023–2030 (USD MILLION) 164
TABLE 147 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY TYPE,
2023–2030 (THOUSAND UNITS) 165
TABLE 148 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023–2030 (USD MILLION) 165
TABLE 149 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 165
TABLE 150 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY END USER,
2023–2030 (USD MILLION) 166
TABLE 151 GCC COUNTRIES: RIGID ENDOSCOPES MARKET, BY TYPE,
2023–2030 (USD MILLION) 167
TABLE 152 GCC COUNTRIES: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023–2030 (USD MILLION) 167
TABLE 153 GCC COUNTRIES: RIGID ENDOSCOPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 167
TABLE 154 GCC COUNTRIES: RIGID ENDOSCOPES MARKET, BY END USER,
2023–2030 (USD MILLION) 168
TABLE 155 REST OF MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 156 REST OF MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET,
BY CLINICAL USAGE, 2023–2030 (USD MILLION) 169
TABLE 157 REST OF MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 169
TABLE 158 REST OF MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET,
BY END USER, 2023–2030 (USD MILLION) 169
TABLE 159 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN
RIGID ENDOSCOPES MARKET 170
TABLE 160 RIGID ENDOSCOPES MARKET: DEGREE OF COMPETITION 173
TABLE 161 RIGID ENDOSCOPES MARKET: REGION FOOTPRINT 178
TABLE 162 RIGID ENDOSCOPES MARKET: TYPE FOOTPRINT 179
TABLE 163 RIGID ENDOSCOPES MARKET: APPLICATION FOOTPRINT 180
TABLE 164 RIGID ENDOSCOPES MARKET: END-USER FOOTPRINT 181
TABLE 165 RIGID ENDOSCOPES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 183
TABLE 166 RIGID ENDOSCOPES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY TYPE AND REGION 184
TABLE 167 RIGID ENDOSCOPES MARKET: PRODUCT LAUNCHES,
JANUARY 2022–SEPTEMBER 2025 186
TABLE 168 RIGID ENDOSCOPES MARKET: DEALS, JANUARY 2022–SEPTEMBER 2025 187
TABLE 169 OLYMPUS CORPORATION: COMPANY OVERVIEW 188
TABLE 170 OLYMPUS CORPORATION: PRODUCTS OFFERED 189
TABLE 171 OLYMPUS CORPORATION: DEALS, JANUARY 2022–SEPTEMBER 2025 191
TABLE 172 KARL STORZ SE & CO. KG: COMPANY OVERVIEW 193
TABLE 173 KARL STORZ SE & CO. KG: PRODUCTS OFFERED 193
TABLE 174 KARL STORZ SE & CO. KG: PRODUCT LAUNCHES,
JANUARY 2022–SEPTEMBER 2025 195
TABLE 175 KARL STORZ SE & CO. KG: DEALS, JANUARY 2022–SEPTEMBER 2025 195
TABLE 176 STRYKER: COMPANY OVERVIEW 197
TABLE 177 STRYKER: PRODUCTS OFFERED 198
TABLE 178 SMITH+NEPHEW: COMPANY OVERVIEW 200
TABLE 179 SMITH+NEPHEW: PRODUCTS OFFERED 201
TABLE 180 B. BRAUN SE: COMPANY OVERVIEW 203
TABLE 181 B. BRAUN SE: PRODUCTS OFFERED 204
TABLE 182 MEDTRONIC: COMPANY OVERVIEW 206
TABLE 183 MEDTRONIC: PRODUCTS OFFERED 207
TABLE 184 MEDTRONIC: DEALS, JANUARY 2022–SEPTEMBER 2025 208
TABLE 185 NIPRO: COMPANY OVERVIEW 209
TABLE 186 NIPRO: PRODUCTS OFFERED 210
TABLE 187 RICHARD WOLF GMBH: COMPANY OVERVIEW 211
TABLE 188 RICHARD WOLF GMBH: PRODUCTS OFFERED 211
TABLE 189 RICHARD WOLF GMBH: DEALS, JANUARY 2022–SEPTEMBER 2025 212
TABLE 190 CONMED CORPORATION: COMPANY OVERVIEW 213
TABLE 191 CONMED CORPORATION: PRODUCTS OFFERED 214
TABLE 192 ARTHREX, INC.: COMPANY OVERVIEW 215
TABLE 193 ARTHREX, INC.: PRODUCTS OFFERED 215
TABLE 194 FUJIFILM CORPORATION: COMPANY OVERVIEW 216
TABLE 195 HOLOGIC, INC.: COMPANY OVERVIEW 217
TABLE 196 SHANGRAO WS MEDTECH CO., LTD.: COMPANY OVERVIEW 218
TABLE 197 ATMOS MEDIZINTECHNIK GMBH & CO. KG: COMPANY OVERVIEW 219
TABLE 198 HENKE-SASS WOLF: COMPANY OVERVIEW 220
TABLE 199 RUDOLF MEDICAL GMBH + CO. KG: COMPANY OVERVIEW 221
TABLE 200 ENDOMED SYSTEMS GMBH: COMPANY OVERVIEW 222
TABLE 201 TELEFLEX INCORPORATED: COMPANY OVERVIEW 223
TABLE 202 INTEGRATED ENDOSCOPY: COMPANY OVERVIEW 224
TABLE 203 NEOSCOPE INC.: COMPANY OVERVIEW 225
TABLE 204 ECLERIS: COMPANY OVERVIEW 226
TABLE 205 NANCHANG WOEK MEDICAL TECHNOLOGY CO., LTD: COMPANY OVERVIEW 227
TABLE 206 KASHMIR SURGICAL WORKS: COMPANY OVERVIEW 228
TABLE 207 OPTOMIC: COMPANY OVERVIEW 229
TABLE 208 HIPP ENDOSKOP SERVICE GMBH: COMPANY OVERVIEW 230
FIGURE 1 RIGID ENDOSCOPES MARKET SEGMENTATION & REGIONAL SCOPE 24
FIGURE 2 RIGID ENDOSCOPES MARKET: YEARS CONSIDERED 26
FIGURE 3 RIGID ENDOSCOPES MARKET: RESEARCH DESIGN 28
FIGURE 4 RIGID ENDOSCOPES MARKET: KEY DATA FROM SECONDARY SOURCES 30
FIGURE 5 RIGID ENDOSCOPES MARKET: KEY PRIMARY SOURCES 31
FIGURE 6 RIGID ENDOSCOPES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS 32
FIGURE 7 RIGID ENDOSCOPES MARKET: KEY DATA FROM PRIMARY SOURCES 33
FIGURE 8 PRIMARY BREAKDOWN OF PRIMARY INTERVIEWS:
BY COMPANY TYPE, DESIGNATION, AND REGION 33
FIGURE 9 RIGID ENDOSCOPES MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 34
FIGURE 10 RIGID ENDOSCOPES MARKET: TOP-DOWN APPROACH 35
FIGURE 11 IMPACT ANALYSIS OF MARKET DYNAMICS, 2025–2030 36
FIGURE 12 RIGID ENDOSCOPES MARKET: CAGR PROJECTIONS 37
FIGURE 13 RIGID ENDOSCOPES MARKET: DATA TRIANGULATION METHODOLOGY 38
FIGURE 14 RIGID ENDOSCOPES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 41
FIGURE 15 RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2025 VS. 2030 (USD MILLION) 42
FIGURE 16 RIGID ENDOSCOPES MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 42
FIGURE 17 RIGID ENDOSCOPES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 43
FIGURE 18 REGIONAL SNAPSHOT OF RIGID ENDOSCOPES MARKET 44
FIGURE 19 RISING REQUIREMENT FOR ENDOSCOPY TO DIAGNOSE AND TREAT TARGET DISEASES TO DRIVE MARKET GROWTH 45
FIGURE 20 US AND HOSPITALS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN RIGID ENDOSCOPES MARKET IN 2024 46
FIGURE 21 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 47
FIGURE 22 MIDDLE EAST & AFRICA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 47
FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 48
FIGURE 24 RIGID ENDOSCOPES MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 49
FIGURE 25 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN RIGID ENDOSCOPES MARKET 55
FIGURE 26 RIGID ENDOSCOPES MARKET: VALUE CHAIN ANALYSIS 58
FIGURE 27 RIGID ENDOSCOPES MARKET: SUPPLY CHAIN ANALYSIS 59
FIGURE 28 RIGID ENDOSCOPES MARKET: ECOSYSTEM ANALYSIS 60
FIGURE 29 RIGID ENDOSCOPES MARKET: FUNDING SCENARIO AND NUMBER OF DEALS, 2019–2023 (USD MILLION) 61
FIGURE 30 RIGID ENDOSCOPES MARKET: PATENT ANALYSIS,
JANUARY 2015–SEPTEMBER 2025 72
FIGURE 31 TOP APPLICANTS FOR RIGID ENDOSCOPES, JANUARY 2015−SEPTEMBER 2025 73
FIGURE 32 RIGID ENDOSCOPES MARKET: PORTER’S FIVE FORCES ANALYSIS 76
FIGURE 33 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF TOP THREE APPLICATIONS 78
FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 79
FIGURE 35 FLEXIBLE ENDOSCOPES MARKET OVERVIEW 80
FIGURE 36 AI USE CASES IN RIGID ENDOSCOPES MARKET 82
FIGURE 37 RIGID ENDOSCOPES MARKET: GEOGRAPHIC SNAPSHOT 118
FIGURE 38 NORTH AMERICA: RIGID ENDOSCOPES MARKET SNAPSHOT 120
FIGURE 39 ASIA PACIFIC: RIGID ENDOSCOPES MARKET SNAPSHOT 142
FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN RIGID ENDOSCOPES MARKET
(2020–2024) 172
FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN
RIGID ENDOSCOPES MARKET (2024) 173
FIGURE 42 RIGID ENDOSCOPES MARKET: COMPANY EVALUATION
MATRIX (KEY PLAYERS), 2024 176
FIGURE 43 RIGID ENDOSCOPES MARKET: COMPANY FOOTPRINT 177
FIGURE 44 RIGID ENDOSCOPES MARKET: COMPANY EVALUATION
MATRIX (STARTUPS/SMES), 2024 182
FIGURE 45 EV/EBITDA OF KEY VENDORS 185
FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 185
FIGURE 47 RIGID ENDOSCOPES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 186
FIGURE 48 OLYMPUS CORPORATION: COMPANY SNAPSHOT 189
FIGURE 49 STRYKER: COMPANY SNAPSHOT 198
FIGURE 50 SMITH+NEPHEW: COMPANY SNAPSHOT 201
FIGURE 51 B. BRAUN SE: COMPANY SNAPSHOT 204
FIGURE 52 MEDTRONIC: COMPANY SNAPSHOT 207
FIGURE 53 NIPRO: COMPANY SNAPSHOT 210
FIGURE 54 CONMED CORPORATION: COMPANY SNAPSHOT 214
同分類最新報告（醫療器材）
查看醫療器材全部報告 →
量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們